On May 28, 2025, Edesa Biotech, Inc. held its Annual Meeting where shareholders approved an amendment to the 2019 Equity Incentive Compensation Plan, increasing share issuance by 1,725,000 and changing stock options. The meeting also confirmed board directors, executive compensation, and appointed new auditors, with 46% of shares voting.